Answers are grounded in this paper and cite their sources.
The study demonstrates how tissue signals regulate Aiolos expression in ILC2s, suggesting a novel target for type 2 inflammation.
ILC2s through inhibiting PD-1. At the epigenetic level, ILC2 tissue characters are imprinted by open chromatin regions (OCRs) at non-promoters. Intestinal-specific transcription factor aryl hydrocarbon receptor (Ahr) binds to Ikzf3 (encoding Aiolos) locus, increases the accessibility of an intestinal ILC2-specific OCR, and promotes the Ikzf3 transcription by enhancing H3K27ac. Consequently, Ahr prevents ILC2s entering an "exhausted-like" state through sustaining Aiolos expression. Our work elucidates mechanism of ILC2 tissue adaptation and highlights Aiolos as a potential target of type 2 inflammation.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: